CIENCIASMEDICASNEWS: Medical News | Medical Articles | Discovery of potential cause of age-related macular degeneration

lunes, 16 de marzo de 2020

Medical News | Medical Articles | Discovery of potential cause of age-related macular degeneration

	Ophthalmology / Optometry
	The latest ophthalmology / optometry news from News Medical

Discovery of potential cause of age-related macular degeneration

Age related macular degeneration or AMD leads to loss of vision in around 1.5 million people in the United Kingdom and millions of others around the world. In a new study researchers have discovered a new protein that could explain the causation and thus provide clues to its early diagnosis and effective treatment. The study was published in the latest issue of the journal Nature Communications.

			USF neuroscientists prove eye pressure is sufficient to cause and explain glaucoma Neuroscientists at the University of South Florida have become the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

			Evaluating the safety and effectiveness of investigational drug to manage pediatric myopia SUNY College of Optometry will take part in a multi-center US clinical trial sponsored by Eyenovia, Inc. to evaluate the safety and effectiveness of an investigational drug, MicroPine, to help slow myopic progression in children 3 to 12 years old.

	Researchers develop smart contact lens sensor for point-of-care eye health monitoring A research group led by Prof. DU Xuemin from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences has developed a "smart" contact lens that can show real-time changes in moisture and pressure by altering colors.

	Scientists make important discovery with implications for people living with AMD Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease (age-related macular degeneration, AMD) that can cause blindness.

	Gene therapy approach could pave the way for treatment of Stargardt disease A leading Professor of Ophthalmology at the University of Oxford has shared the details of his research which could pave the way for a new treatment for sight loss condition Stargardt disease.

	New treatment effective at reversing the manifestations of thyroid eye disease Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.